Mukka Proteins to hold virtual analyst meeting with IFC on Sep 25

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Mukka Proteins Limited scheduled a virtual meeting with IFC for September 25, 2026
  • The interaction is a one-on-one analyst/institutional investor engagement
  • No unpublished price sensitive information will be shared during the meeting
  • Latest investor presentation is available on the company website
powered bylight_fuzz_icon
51635599

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited will host a virtual one-on-one meeting with the International Finance Corporation (IFC) on September 25, 2026. The company confirmed the schedule in a filing to stock exchanges, marking an engagement with a major institutional investor.

Meeting Details

The interaction is classified as an analyst and institutional investor meeting. The company stated that no unpublished price sensitive information will be disclosed or shared during the session.

Day / Date Name of Fund / Investor Venue / Mode Nature of Meeting
Friday, September 25, 2026 International Finance Corporation (IFC) Virtual Meeting One on One

Regulatory Compliance and Resources

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the schedule may undergo changes at the discretion of the analyst, institutional investor, or the company.

Investors can access the latest investor presentation on the company's official website. The filing was signed by Mehaboobsab Mahmadoous Chalyal, Company Secretary & Compliance Officer.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-3.12%-14.92%+2.93%+29.53%-2.11%-35.22%

How might Mukka Proteins' engagement with the IFC influence its access to international capital markets or ESG-compliant financing in the coming fiscal year?

Could this meeting signal a potential equity stake or debt investment by the IFC, and what impact would such an entry have on Mukka Proteins' shareholding pattern?

What specific growth initiatives or expansion plans is Mukka Proteins likely highlighting to attract institutional interest from a development finance institution like the IFC?

Mukka Proteins to host virtual investor meet with ADD Capital

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Mukka Proteins to hold virtual one-on-one meet with ADD Capital
  • Session scheduled for September 17, 2026
  • Disclosure made under SEBI LODR Regulation 30
  • No unpublished price-sensitive information to be shared
powered bylight_fuzz_icon
50752623

*this image is generated using AI for illustrative purposes only.

Mukka Proteins will conduct a virtual one-on-one meeting with ADD Capital on September 17, 2026. The engagement is part of the company's ongoing dialogue with institutional investors.

The company notified the National Stock Exchange of India Limited and BSE Limited of the scheduled interaction. This disclosure aligns with compliance requirements for investor communication.

Meeting Details

The session will take place via virtual mode. It is structured as a one-on-one discussion between the company representatives and the fund manager.

Date Investor Mode Nature
September 17, 2026 ADD Capital Virtual One on One

Regulatory Compliance

Mukka Proteins made this intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company emphasized that no unpublished price-sensitive information will be shared during the meeting.

Investors can access the latest presentation on the company's website. Mehaboobsab Mahmadgous Chalyal, Company Secretary and Compliance Officer, signed the disclosure.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-3.12%-14.92%+2.93%+29.53%-2.11%-35.22%

How might ADD Capital's engagement signal broader institutional interest in Mukka Proteins' growth trajectory?

What specific strategic initiatives or financial metrics are likely to be the focal points of this one-on-one discussion?

Could this targeted investor outreach precede an upcoming earnings announcement or major corporate action?

More News on Mukka Proteins

1 Year Returns:-2.11%